Suppr超能文献

针对精神障碍患者的伦理研究。

Ethical research with the mentally disordered.

作者信息

Arboleda-Flórez J, Weisstub D N

机构信息

Faculty of Law, University of Calgary, Alberta.

出版信息

Can J Psychiatry. 1997 Jun;42(5):485-91. doi: 10.1177/070674379704200504.

Abstract

Because of concerns about competence and voluntariness, the mentally disordered constitute a vulnerable population in the context of nontherapeutic biomedical research and, as such, are in need of protection. Despite others' concern about protecting the mentally disordered, their decision-making potential should also be respected and maximized, allowing such individuals to consent to participate in experiments subject to an evaluation of their competence to make such a decision. Competent mentally disordered persons who anticipate future incapacity should be able to issue research directives or durable powers of attorney whereby they can provide explicit consent to participate in nontherapeutic research. When he or she becomes incompetent, a substitute decision maker should be able to provide consent on behalf of the mentally disordered person within established parameters. Nontherapeutic experimentation with the mentally disordered should be permitted, but only within the boundaries of ethical permissibility delineated by legislated guidelines. At present, the legal status of substituted consent for nontherapeutic procedures is uncertain and requires legislation, which in addition to legalizing such consent, would provide guidelines for substitute decision makers and for the creation of research directives. These guidelines should include restrictions on the scope of research, obligations of researchers, rights of subjects, and responsibilities of research ethics committees (RECs). In all cases, the voluntary and informed consent of the person or substitute decision maker must be obtained.

摘要

由于对能力和自愿性的担忧,在非治疗性生物医学研究背景下,精神障碍患者构成了弱势群体,因此需要得到保护。尽管其他人关注保护精神障碍患者,但他们的决策潜力也应得到尊重并最大化发挥,允许这些个体在对其做出此类决定的能力进行评估后同意参与实验。预期未来无行为能力的有行为能力的精神障碍患者应能够发布研究指示或持久授权书,据此他们可以明确同意参与非治疗性研究。当他或她变得无行为能力时,替代决策者应能够在既定范围内代表精神障碍患者提供同意。对精神障碍患者进行非治疗性实验应被允许,但只能在法律规定的伦理允许范围内进行。目前,非治疗性程序的替代同意的法律地位尚不确定,需要立法,这除了使这种同意合法化外,还将为替代决策者和制定研究指示提供指导方针。这些指导方针应包括对研究范围的限制、研究人员的义务、受试者的权利以及研究伦理委员会(RECs)的职责。在所有情况下,必须获得个人或替代决策者的自愿和知情同意。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验